Alnylam Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Alnylam Pharmaceuticals Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Alnylam Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Alnylam Pharmaceuticals Inc.

Back to companies

Alnylam Pharmaceuticals Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Alnylam Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Alnylam Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Yvonne L. Greenstreet, M.D.

Chief Executive Officer; Director Executive Board Since: 2022 Age: 63

Dr Yvonne L. Greenstreet has been the Chief Executive Officer and Director of the company since 2022. Prior to this, she served as the President and Chief Operating Officer of the company since 2020. Previously, she served as the Senior Vice President and Head of Medicines Development at Pfizer. He also served as the Senior Vice President and Chief of Strategy for Research and Development, Senior Vice President for Medicines Development, and Chief Medical Officer of Europe at GlaxoSmithKline plc.

Read Hide full bio of Yvonne L. Greenstreet, M.D.

Amy W. Schulman

Chair Executive Board Since: 2023 Age: 65

Ms Amy W. Schulman has been the Chairman of the company since 2023. Prior to this, she served as the Director of the company. Previously, she served as the Executive Chair at Lyndra Therapeutics, Inc. She served as the Executive Vice President and General Counsel at Pfizer. She also served as the Director at Elevance Health and Director at Fractyl Health, Inc., SQZ Biotech and Hudson Executive Investment Corp.

Read Hide full bio of Amy W. Schulman

Jeffrey V. Poulton

Chief Financial Officer; Executive Vice President Senior Management Since: 2019 Age: 58

Mr. Jeffrey V. Poulton has been the Chief Financial Officer and Executive Vice President of the company since 2019. Prior to this, he served as the Chief Financial Officer at Indigo Agriculture. Mr. Poulton also served as the Chief Financial Officer of Shire.

Read Hide full bio of Jeffrey V. Poulton

Bryan Supran

Chief Legal Officer; Executive Vice President Senior Management Age: 55

Mr Bryan Supran has been the Chief Legal Officer of the company since 2025. Prior to this, he served as the Senior Vice President and Deputy General Counsel at Pfizer.

Read Hide full bio of Bryan Supran

Piyush Sharma

Chief Compliance Officer; Chief Ethics Officer Senior Management Since: 2022

Mr. Piyush Sharma has been the Chief Ethics Officer and Chief Compliance Officer of the company since 2022. Prior to this, he served as the Senior Vice President and Head of Compliance, Alexion, AstraZeneca Rare Disease at Alexion Pharmaceuticals Inc. Previously, he served as the Deputy Compliance Officer, Anti-Bribery & Anti-Corruption Programs at Hess Corporation.

Read Hide full bio of Piyush Sharma
Gain a 360-degree view of Alnylam Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Alnylam Pharmaceuticals Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer